What's in a label? Ecstasy sellers' perceptions of pill brands.

This article presents selected findings from a qualitative study of Ecstasy sellers and their sales practices, knowledge of distribution networks, buyer-seller relationships, and self-reported drug use. In-depth interviews were conducted with 80 men and women who had sold five or more hits of Ecstasy five or more times in the six months prior to the interview. Study participants described their perceptions of the various types of Ecstasy they had distributed or used themselves.

Maximising the highs and minimising the lows: harm reduction guidance within ecstasy distribution networks.

Background: Little is known about how users build and share knowledge concerning the highs and lows of Ecstasy and the role that Ecstasy sellers play in the exchange of this information.

Methods: These findings are based on a National Institute on Drug Abuse-funded project, "An Exploratory Study of Ecstasy Distribution," conducted between 2003 and 2006. We completed in-depth interviews with 120 men and women in the San Francisco Bay Area who had sold 5 or more doses 5 or more times in the 6 months prior to the interview.

Walking the tightrope: balancing health and drug use.

This article stems from a study on San Francisco drug users and their health care experiences. Two hundred thirty-eight study participants were administered depth interviews and questionnaires to reveal a variety of health concerns and health behaviors. For these analyses, which focused on health practices and risky behaviors, the sample was divided into two groups: marijuana users, and other drug users (including methamphetamine, cocaine, heroin, and crack).